Cell Impact (Sweden) Performance

CI Stock   0.20  0.02  9.09%   
The firm shows a Beta (market volatility) of 0.82, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Cell Impact's returns are expected to increase less than the market. However, during the bear market, the loss of holding Cell Impact is expected to be smaller as well. At this point, Cell Impact AB has a negative expected return of -0.75%. Please make sure to confirm Cell Impact's value at risk, as well as the relationship between the daily balance of power and price action indicator , to decide if Cell Impact AB performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Cell Impact AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
  

Cell Impact Relative Risk vs. Return Landscape

If you would invest  38.00  in Cell Impact AB on November 3, 2025 and sell it today you would lose (18.00) from holding Cell Impact AB or give up 47.37% of portfolio value over 90 days. Cell Impact AB is currently producing negative expected returns and takes up 7.933% volatility of returns over 90 trading days. Put another way, 71% of traded stocks are less volatile than Cell, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Cell Impact is expected to under-perform the market. In addition to that, the company is 10.7 times more volatile than its market benchmark. It trades about -0.09 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.07 per unit of volatility.

Cell Impact Target Price Odds to finish over Current Price

The tendency of Cell Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.20 90 days 0.20 
about 84.46
Based on a normal probability distribution, the odds of Cell Impact to move above the current price in 90 days from now is about 84.46 (This Cell Impact AB probability density function shows the probability of Cell Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Cell Impact has a beta of 0.82 suggesting as returns on the market go up, Cell Impact average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Cell Impact AB will be expected to be much smaller as well. Additionally Cell Impact AB has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Cell Impact Price Density   
       Price  

Predictive Modules for Cell Impact

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cell Impact AB. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cell Impact's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.010.208.13
Details
Intrinsic
Valuation
LowRealHigh
0.010.198.12
Details
Naive
Forecast
LowNextHigh
00.158.08
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.160.200.24
Details

Cell Impact Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Cell Impact is not an exception. The market had few large corrections towards the Cell Impact's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cell Impact AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cell Impact within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.79
β
Beta against Dow Jones0.82
σ
Overall volatility
0.09
Ir
Information ratio -0.1

Cell Impact Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cell Impact for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cell Impact AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Cell Impact AB generated a negative expected return over the last 90 days
Cell Impact AB has high historical volatility and very poor performance
Cell Impact AB has some characteristics of a very speculative penny stock
Cell Impact AB has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 71.35 M. Net Loss for the year was (79.85 M) with profit before overhead, payroll, taxes, and interest of 34.88 M.
Cell Impact generates negative cash flow from operations
About 17.0% of the company shares are held by company insiders

Cell Impact Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cell Stock often depends not only on the future outlook of the current and potential Cell Impact's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cell Impact's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding59.2 M
Cash And Short Term Investments28.6 M

Cell Impact Fundamentals Growth

Cell Stock prices reflect investors' perceptions of the future prospects and financial health of Cell Impact, and Cell Impact fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cell Stock performance.

About Cell Impact Performance

Assessing Cell Impact's fundamental ratios provides investors with valuable insights into Cell Impact's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Cell Impact is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.

Things to note about Cell Impact AB performance evaluation

Checking the ongoing alerts about Cell Impact for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cell Impact AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Cell Impact AB generated a negative expected return over the last 90 days
Cell Impact AB has high historical volatility and very poor performance
Cell Impact AB has some characteristics of a very speculative penny stock
Cell Impact AB has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 71.35 M. Net Loss for the year was (79.85 M) with profit before overhead, payroll, taxes, and interest of 34.88 M.
Cell Impact generates negative cash flow from operations
About 17.0% of the company shares are held by company insiders
Evaluating Cell Impact's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Cell Impact's stock performance include:
  • Analyzing Cell Impact's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cell Impact's stock is overvalued or undervalued compared to its peers.
  • Examining Cell Impact's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Cell Impact's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cell Impact's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Cell Impact's stock. These opinions can provide insight into Cell Impact's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Cell Impact's stock performance is not an exact science, and many factors can impact Cell Impact's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for Cell Stock Analysis

When running Cell Impact's price analysis, check to measure Cell Impact's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cell Impact is operating at the current time. Most of Cell Impact's value examination focuses on studying past and present price action to predict the probability of Cell Impact's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cell Impact's price. Additionally, you may evaluate how the addition of Cell Impact to your portfolios can decrease your overall portfolio volatility.